Status:
COMPLETED
An Observational Study of Fungal Biomarkers (MK-0000-089)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Aspergillosis
Eligibility:
All Genders
16+ years
Brief Summary
The purpose of this study is to evaluate the relationship between fungal biomarker levels during anti-fungal therapy and the success of treatment for fungal infection. The primary hypothesis is that o...
Eligibility Criteria
Inclusion
- Is 16 years of age or older
- Female is either post-menopausal, surgically sterilized, willing to use 2 adequate methods of birth control, or agrees to abstain from heterosexual activity throughout the study
- Female of child bearing potential must have a negative pregnancy test
- Male is surgically sterilized, agrees to use an adequate method of contraception, or agrees to abstain from heterosexual activity for the duration of the study
- Has possible, probable, or confirmed invasive aspergillosis (IA)
- Has had a computed tomography (CT) or magnetic resonance imaging (MRI) scan 72 hours prior to initiation of anti-fungal therapy
Exclusion
- Has had hemodialysis using cellulose membrane within 2 weeks of study start
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT00854607
Start Date
March 1 2009
End Date
August 1 2011
Last Update
August 21 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.